record

MVP Recovery LLC

Media, PA

Medication used in treatmentDirectory coverage. Read the methodology and limitations.

Facility contact

Care types: Substance use treatment Source
Care settings: Outpatient, Outpatient day treatment or partial hospitalization, Intensive outpatient treatment, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment Source
OUD medication support: Medication used in treatment Source
Opioid medications: Buprenorphine used in Treatment, Naltrexone used in Treatment Source
Opioid treatment responses: Buprenorphine maintenance, Prescribes buprenorphine, Prescribes naltrexone, Relapse prevention with naltrexone, Accepts clients using MAT but prescribed elsewhere, Maintenance service with medically supervised withdrawal after stabilization Source
Other pharmacotherapies: Acamprosate (Campral®), Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable), Naltrexone (oral), Naltrexone (extended-release, injectable), Medication for mental disorders, Non-nicotine smoking/tobacco cessation Source
Treatment approaches: Anger management, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling, Trauma-related counseling Source

Payment methods: Federal, or any government funding for substance use treatment programs, Medicaid, Private health insurance Source
Telehealth reported: No Source
Transportation assistance: Yes Source
Ancillary services: Case management service, Mental health services, Transportation assistance Source

Age groups: Children/Adolescents, Young Adults, Adults, Seniors Source
Co-occurring treatment reported: No Source
All oversight and accreditation responses: State substance use treatment agency Source
Facility operation: Private for-profit organization Source
Directory field completeness: 100 / 100 Source

Research workflow

Unlock shortlist comparison, local notes, export, and complete directory context.